Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines

By Tieva Åse   Bergh Anders   Damber Jan-Erik  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 299-303

Informa Healthcare

Access to resources Recommend Favorite

Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer

By Debruyne Frans   Bhat Gajanan   Garnick Marc B  

Future Oncology, Vol. 2, Iss. 6, 2006-12 ,pp. : 677-696

Future Medicine

Access to resources Recommend Favorite

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

By Lauro Luigi   Vici Patrizia   Medico Pietro   Laudadio Lucio   Tomao Silverio   Giannarelli Diana   Pizzuti Laura   Sergi Domenico   Barba Maddalena   Maugeri-Saccà Marcello  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite

Involvement of Annexin V in Antiproliferative Effects of Gonadotropin-Releasing Hormone Agonists on Human Endometrial Cancer Cell Line

By Shibata S.   Sato H.   Ota H.   Karube A.   Takahashi O.   Tanaka T.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 217-221

Elsevier

Access to resources Recommend Favorite

Single nucleotide polymorphisms in the regulatory region of gonadotropin-releasing hormone receptor gene and breast cancer susceptibility

By              

Oncology Reports, Vol. 28, Iss. 3, 2012-01 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite